Forte Biosciences, Inc. Common Stock

FBRXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
48.86 USD
↗ 3.87 (8.60%)AT CLOSE (11:59 AM EDT)
48.78
↘ 0.08 (0.16%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
48.78
↘ 0.08 (0.16%)
🔴Market: CLOSED

Forte Biosciences, Inc. Common Stock (FBRX) trades at $48.86 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, FBRX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jul 17, 2026.

Open?$43.35
High?$50.00
Low?$42.00
Prev. Close?$44.99
Volume?595.9K
Avg. Volume?707.6K
VWAP?$47.41
Rel. Volume?0.84x
Bid / Ask
Bid?$48.93 × 500
Ask?$52.88 × 100
Spread?$3.95
Midpoint?$50.91
Valuation & Ratios
Market Cap?1.0B
Shares Out?20.5M
Float?7.5M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?23.77
EPS?-$3.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
22
Market Cap
921.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortebiorx.com
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
13
Piotroski F-Score?0/9Weak
Altman Z-Score?15.75Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.19%Squeeze Risk
Short Interest?1.9M
Days to Cover?3.5
Free Float7.5M
Avg Daily Volume544.3K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
23.77HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-180.2%WEAK▾
ROA?
S&P
3
-112.8%WEAK▾
Cash Flow & Enterprise
FCF?$-59390000
Enterprise Value?$942.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist